Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(40.0%)
Phase 2
1(20.0%)
Phase 4
1(20.0%)
Phase 3
1(20.0%)
5Total
N/A(2)
Phase 2(1)
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02976688Phase 2Unknown

Effects of Short-chain Fatty Acids on Inflammatory and Metabolic Parameters in Maintenance Hemodialysis

Role: lead

NCT02302287Phase 4Unknown

Renal Effects of Meditarranean Diet and Low-protein Diet With Ketoacids on Physiological Intestinal Mibrobiota in CKD

Role: lead

NCT01640119Phase 3Unknown

Correction of Metabolic Acidosis in End Stage Renal Disease (ESRD)

Role: lead

NCT00710788Not ApplicableCompleted

Reduce Cardiovascular Calcifications to Reduce QT Interval in Dialysis

Role: lead

NCT00323713Not ApplicableUnknown

Very Low Protein Diet and Renal Death in Chronic Kidney Disease (CKD)-ERIKA Study

Role: lead

All 5 trials loaded